Altered Calcium Homeostasis and Membrane Integrity in Myocardial Cell Injury
Coronary occlusion leads to contractile arrest of ischemic myocardium and progressive metabolic derangements and ultrastructural alterations, which if of sufficient duration and severity, lead to irreversible myocardial injury. Based on a number of experimental observations, we and others have put forward the following general hypothesis regarding the pathogenesis of irreversible myocardial injury1,2. Myocardial ischemia causes oxygen deprivation which leads to depressed energy metabolism resulting in a reduced ATP level, increased lactate, and decreased pH. The metabolic changes are followed by discrete alterations in energy dependent membrane transport systems which lead to altered ionic composition of the cell, including an increase in cytosolic calcium. These membrane alterations may include altered ionic flux across the sarcolemma as well as release of calcium from mitochondria and sarcoplasmic reticulum. The elevated cytosolic calcium concentration has the potential to activate catabolic enzymes, including phospholipases. This may lead to acceleration phosphlipid degradation, increased membrane permeability, and further electrolyte derangements, including calcium accumulation. The excess cellular calcium load may also lead to ATP depletion by activation of calcium-dependent ATPases as well as by mitochondrial calcium accumulation which occurs at the expense of continued energy production. Thereafter, a vicious cycle of membrane injury and ATP depletion may ensue which terminates in irreversible cell injury. Observations pertinent to this hypothesis are reviewed in this chapter.
KeywordsCoronary Occlusion Total Phospholipid Calcium Overload Membrane Injury Irreversible Injury
Unable to display preview. Download preview PDF.
- 2.J.T. Willerson, A. Mukherjee, K. Chien, C. Ezquierdo, and L.M. Buja, Calcium and acute myocardial infraction, in: “Calcium Antagonists and Cardiovascular Disease”, L.H. Opie, ed., Raven Press, New York, p 257 (1984).Google Scholar
- 4.L.M. Buja, A.J. Tofe, P.V. Kulkarni, A. Mukherjee, R.W. Parkey, M.D. Francis, F.J. Bonte, and J.T. Willerson, Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues, J. Clin. Invest. 60:724 (1977).PubMedCrossRefGoogle Scholar
- 16.L.M. Buja, H.K. Muntz, T. Rosenbaum, Z. Haghani, D.K. Buja, A. Sen, K.R. Chien, and J.T. Willerson, Characterization of a potentially reversible increase in beta adrenergic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism, Cir. Res. 57:640 (1985).CrossRefGoogle Scholar
- 22.K.R. Chien, J.P. Reeves, L.M. Buja, F.J. Bonte, R.W. Parkey, and J.T. Willerson, Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect, Cir. Res. 48:711 (1981).CrossRefGoogle Scholar
- 24.K.P. Burton, L.M. Buja, A. Sen, J.T. Willerson, and K.R. Chien, Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart: correlation with the loss of contractile function and the development of calcium overload, Am. J. Pathol. 124:238 (1986).PubMedGoogle Scholar
- 26.K.R. Chien, A. Sen, R.C. Reynolds, A. Chang, Y. Kim, M.D. Gunn, L.M. Buja, and J.T. Willerson, Release of arachidonate from membrane phospholipids in cultured myocardial cells during ATP depletion: correlation with the progression of cell injury, J. Clin. Invest. 75:1770 (1985).PubMedCrossRefGoogle Scholar
- 27.M.D. Gunn, A. Sen, A. Chang, J.T. Willerson, L.M. Buja, and K.R. Chien, Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion, Am. J. Physiol. 249:H1188 (1985).Google Scholar
- 28.L.M. Buja, P.K. Williams, D.K. Buja, K.R. Chien, and J.T. Willerson, Comparative effects of cardiac myocyte injury induced by inhibition of the Na+, K+ pump and intermediary metabolism, Clin. Res. 34:627A (1986).Google Scholar
- 29.A.C. Morris, P.K. Williams, F.A. Lattanzio, D.J. Bellotto, H.K. Hagler, J.T. Willerson, and L.M. Buja, Altered calcium homeostasis induced by Na+, K+ pump inhibition in cultured ventricular myocytes, Circulation 74 (Suppl II): 11–418 (1986).Google Scholar
- 30.D.K. Das, R.M. Engleman, J.A. Rousou, R.H. Breyer, H. Otani, and S. Lemeshow, Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion, Am. J. Physiol. 251:H71 (1986).Google Scholar
- 31.K. Chien, A. Sen, Y. Kim, K. Burton, L.M. Buja, and J.T. Willerson, Biochemical characterization of a new synthetic myocardial phospho-lipase inhibitor: effects on myocardial cells during ATP depletion, Circulation 70 (Suppl II): II278 (1984).Google Scholar